NanosanguisS.A.Active
Research and experimental development in natural sciences and engineering
KRS: 0000595165 NIP: 7010537389 REGON: 36350517300000
Overview
Registry date
2016-01-12
Share capital
$1,207,235.82
Activity description
Nanosanguis is a biotechnology company focused on utilizing nanotechnology in medicine, specifically in the fields of transplantation and transfusion. It aims to increase the availability of organs for transplantation by developing innovative organ perfusion systems and a safe, effective blood substitute. The company also seeks to enhance organ preservation methods and expand the donor pool by utilizing kidneys from donors after circulatory death.
Registered address
Ul. Rakowiecka 36, 02-532 Warszawa, Poland
Website
nanosanguis.comWebsite active
Email
Email address current
Electronic delivery address
AE:PL-40575-90804-VATFB-13
Accounts
Registered as a VAT taxpayer on 2016-01-29.Active
- 42 1090 1056 0000 0001 4863 9955
- 28 1950 0001 2006 0017 4959 0005
- 12 1950 0001 2006 0017 4959 0002
Authorized Representatives
Ownership
Competitors
| Name | Revenue | Website | |
|---|---|---|---|
| Real ResearchS.A. | $565,296.66 | real-research.com/ | |
| Oasis DiagnosticsS.A. | $282,613.94 | oasis-diagnostics.com | |
| PolbionicaS.A. | $225,022.81 | polbionica.com/ | |
| SatroecgS.A. | $117,301.57 | satroecg.pl | |
| Smart FluidS.A. | $100,333.00 | smartfluid.pl | |
| NanovelosS.A. | $22,690.62 | nanovelos.com | |
| ARES Shield AiS.A. | $21,335.85 | aresshield.ai | |
| NanotheaS.A. | $12,468.28 | nanothea.com | |
| IncellvuS.A. | $6,985.93 | incellvu.pl | |
| MolecureS.A. | $10.77 | molecure.com |
FAQ
Last updated: 2026-07-16